Home›People›Victoria Zellmer
Victoria Zellmer

Victoria Zellmer

Chief Executive Officer at Estrigenix Therapeutics.

Executive
Updated Nov 10, 2026·Latest SEC filing Jul 27, 2026·Suggest an edit

About Victoria Zellmer

Victoria Zellmer is a chief executive officer at Estrigenix Therapeutics.

Experience

This experience comes from Victoria Zellmer's profile and from SEC filings. For roles taken from filings, the years are when the filings name Victoria Zellmer in the role, so the role may have started earlier or lasted longer.

Estrigenix Therapeutics, Inc. Current
Chief Executive Officer
2026 – Present · Wauwatosa, WI
Develops potential treatments for hot flashes and dementia in postmenopausal women.
mHUB Chicago Current
Limited Partner
2020 – Present
Invert
Director of Strategic Accounts
2025 – 2026
MaxCyte, Inc.
Business Development Manager
2023 – 2025
Harvard Bioscience
Senior Account Executive
2018 – 2023
Piper Jaffray
Equity Research Associate
2017 – 2018
University of Notre Dame
Graduate Student Researcher
2012 – 2017
Enlightened Diagnostics
Co-Founder & Chief Science Officer
2014 – 2016

Key Colleagues at Startups

The people Victoria Zellmer works with at each company, as listed on that company's latest Form D.

Estrigenix Therapeutics, Inc. · Form D, Jul 27, 2026
Patricia Scheller
Patricia Scheller
Executive Chair
William Donaldson
William Donaldson
PRESIDENT & Senior VICE PRESIDENT of CHEMISTRY, director
DS
Daniel Sem
Vice President of Business Development and director
Karyn Frick
Karyn Frick
Chief Scientific Officer

Sources

  1. SECEstrigenix Therapeutics, Inc. Form D, filed Jul 27, 2026